PATENT CLAIM ANALYSIS

Application Number: 16142969
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "220000"]

Abstract:
The invention comprises methods of modulating the complement cascade in a mammal and for treating and/or preventing diseases and disorders associated with the complement pathway by administering a compound of Formula I or Formula II, such as, for example, 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one or a pharmaceutically acceptable salt thereof.

Claim (Index 8):
The method of  claim 1 , wherein the compound of Formula I is [2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one], or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 97.0
- Lexical Diversity: 1.31915
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15066513', '11670238', '14513281', '13257082', '13265060']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6958810459230165
- 35 USC 102 Novelty (BERT): 0.6851820687184735
- Combined Prediction Score: 0.6948111482025623
- Mean Citation Score: 395.297994
- Max Citation Score: 685.7202
- Similarity Product: 666.4924885604382

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test